A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias
JACC: Clinical Electrophysiology · 2024-04 · 10 (4) · 750-758
DOI: 10.1016/j.jacep.2023.12.012 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2024-04. Verfasst von Fouad Chouairi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Stellate Ganglion, Tachycardia, Ventricular, Ventricular Fibrillation, Autonomic Nerve Block. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Ventricular tachycardia (VT) and ventricular fibrillation (VF) are life-threatening conditions and can be refractory to conventional drug and device interventions. Stellate ganglion blockade (SGB) has been described as an adjunct, temporizing intervention in patients with refractory ventricular arrhythmia. We examined the association of SGB with VT/VF in a multicenter registry. OBJECTIVES: This study examined the efficacy of SGB for treatment/temporization of refractory VT/VF. METHODS: The authors present the first analysis from a multicenter registry of patients treated for refractory ventricular arrhythmia at a clinical site in the Czech Republic and the United States. Data were collected between 2016 and 2022. SGB was performed at the bedside by anesthesiologists and/or cardiologists. Outcomes of interest were VT/VF burden and defibrillations at 24 hours before and after SGB. RESULTS: In total, there were 117 patients with refractory ventricular arrhythmias treated with SGB at Duke (n = 49) and the Institute for Clinical and Experimental Medicine (n = 68). The majority of patients were male (94.0%), were White (87.2%), and had an implantable cardioverter-defibrillator (70.1%). The most common etiology of heart disease was ischemic cardiomyopathy (52.1%), and monomorphic VT was the most common morphology (70.1%). Within 24 hours before SGB (0-24 hours), the median episodes of VT/VF were 7.5 (Q1-Q3: 3.0-27.0), and 24 hours after SGB, the median decreased to 1.0 (Q1-Q3: 0.0-4.5; P < 0.001). At 24 hours before SGB, the median defibrillation events were 2.0 (Q1-Q3: 0.0-8.0), and 24 hours after SGB, the median decreased to 0.0 (Q1-Q3: 0.0-1.0; P < 0.001). CONCLUSIONS: In the largest cohort of patients with treatment-refractory ventricular arrhythmia, we demonstrate that SGB use was associated with a reduction in the ventricular arrhythmia burden and need for defibrillation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
- Wake Forest Baptist Health, Winston Salem, North Carolina, USA.
- Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- Emory University Hospital, Atlanta, Georgia, USA.
- Division of Cardiology, Department of Internal Medicine, Duke University School of Medicine, Durham, North Carolina, USA; Duke Clinical Research Institute, Durham, North Carolina, USA.
- Division of Anesthesia, Duke University School of Medicine, Durham, North Carolina, USA.
Zitieren
APA
Chouairi, F., Rajkumar, K., Benak, A., Qadri, Y., Piccini, J. P., Mathew, J., Ray, N. D., Toman, J., Kautzner, J., Ganesh, A., Sramko, M., & Fudim, M. (2024). A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias. JACC: Clinical Electrophysiology, 10(4), 750-758. https://doi.org/10.1016/j.jacep.2023.12.012
Vancouver
Chouairi F, Rajkumar K, Benak A, Qadri Y, Piccini JP, Mathew J, et al. A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias. JACC: Clinical Electrophysiology. 2024;10(4):750-758. doi:10.1016/j.jacep.2023.12.012
BibTeX
@article{Chouairi2024,
author = {Chouairi, Fouad and Rajkumar, Karuna and Benak, Ales and Qadri, Yawar and Piccini, Jonathan P and Mathew, Joseph and Ray, Neil D and Toman, Jakub and Kautzner, Josef and Ganesh, Arun and Sramko, Marek and Fudim, Marat},
title = {A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias},
journal = {JACC: Clinical Electrophysiology},
year = {2024},
volume = {10},
number = {4},
pages = {750--758},
doi = {10.1016/j.jacep.2023.12.012}
}
EUVIMED